This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Idiopathic Parkinson Disease
and you are
between 18 and 75
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Implantation of Celavie human stem cells (OK99) is intended to address the underlying pathology of the disease by replacing damaged/destroyed cells of the brain, and/or stimulating the patient's brain to repair itself.

Provided treatments

  • Drug: Human Stem Cells
Tris trial is registered with FDA with number: NCT02780895. The sponsor of the trial is Celavie Bioscences, LLC and it is looking for 8 volunteers for the current phase.
Official trial title:
Human OK99 Allogeneic Stem Cell Transplantation for Patients With Severe Parkinson's Disease